Showing results (1601-1610 of 1,889) with videos related to
Sort By:
Pageof 189
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|October 17, 2022
In vivo identification of the pharmacodynamic ingredients of Polygonum cuspidatum for remedying the mitochondria to alleviate metabolic dysfunction-associated fatty liver diseaseLi-Ping Yu, Yan-Qin Li, Yan-Juan Li, et al.Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|September 12, 2025
Targeted ErbB4 receptor activation ameliorates neuronal deficits via DOCK3 signaling in a transgenic mouse AD modelChong Liu, Yan Zhao, Ji-Ji Dao, et al.Leukemia Research|October 8, 2014
The prognostic utility and the association of serum light chains (free and total) and absolute lymphocyte count in patients with newly diagnosed diffuse large B-cell lymphomaXiaohong Han, Jianfei Wang, Ningning Zhang, et al.Molecular Cancer Therapeutics|September 14, 2019
Morin Inhibits Proliferation and Induces Apoptosis by Modulating the miR-188-5p/PTEN/AKT Regulatory Pathway in CML CellsZi-Yuan Nie, Lin Yang, Xiao-Jun Liu, et al.Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|September 13, 2012
[Evaluation of the role of rhIL-11 on hematological recovery in lymphoma patients after autologous hematopoietic stem cell transplantation]Jian-liang Yang, Yuan-kai Shi, Xiao-hui He, et al.Developmental Cell|June 30, 2026
ARID1A terminates gastric regeneration to prevent cancerAdrian K H Loe, Alyssa Ialongo, Yan Qin, et al.Journal of the American Chemical Society|January 10, 2022
Origin of Ferroelectricity in Two Prototypical Hybrid Organic-Inorganic PerovskitesKai Li, Zhi-Gang Li, Jun Xu, et al.Molecular Pharmaceutics|April 11, 2012
Differential effects of procaspase-3 activating compounds in the induction of cancer cell deathDiana C West, Yan Qin, Quinn P Peterson, et al.Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|August 14, 2012
[Comparative analysis of liver function in HBsAg-/HBcAb+ patients with diffuse large B-cell lymphoma treated with CHOP and R-CHOP regimens]Yan-hua Huang, Xiao-hui He, Yan Qin, et al.Asia-Pacific Journal of Clinical Oncology|August 12, 2020
R-CHOP immunochemotherapy plus surgery is associated with a superior prognosis in Chinese primary intestinal diffuse large B-cell lymphomaFengyi Zhao, Yan Qin, Jianliang Yang, et al.Pageof 189